AbelZeta Pharma

Enabling immunity through innovative T cell-based therapeutics

Rockville, United States · Founded 2009 · $120.0M raised

Employees
201–500
Founded
2009
Business Model
B2B
Total Funding
$120.0M
Last Round
$120.0M Venture Round
Rounds
1

About

AbelZeta Pharma (formerly CBMG Holdings) is a global clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing cell-based therapeutics to address unmet medical needs. With centers of excellence in Rockville, Maryland and Shanghai, China, AbelZeta specializes in CAR-T cell therapy targeting hematologic malignancies, inflammatory and immunological diseases, and solid tumors. Founded in 2009, the company rebranded to AbelZeta Pharma in 2023 and has partnerships with Janssen Biotech (Johnson & Johnson) and AstraZeneca.

Summary

AbelZeta Pharma is a Healthcare company based in Rockville, United States, founded in 2009. It has raised $120.0M in total across 1 round. Investors include Alumni Ventures, EastBridge Investment Group and Sailing Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFunding Round
$120.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AbelZeta Pharma on Indexed.vc
<a href="https://indexed.vc/companies/abelzeta-pharma"><img src="https://indexed.vc/api/badge/company/abelzeta-pharma" alt="AbelZeta Pharma on Indexed.vc" width="260" height="76" /></a>